TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$50 Million

Oxford Immunotec Global

Follow-on Offering

Co-Manager, January 2015

Oxford Immunotec Global PLC is a diagnostic company. It is focused on developing and commercializing proprietary tests for the management of underserved immune regulated conditions. Its products include T-spot TB, T-spot-CMV, T-spot PRT,T-cell extend etc. The company's research and development activities focus on Chronic infections, Transplantation, Autoimmune and Inflammatory disease, Immune oncology.